By |

Profile

Dendreon Corp is a biotechnology company. The Company is engaged in the discovery, development and commercialization of novel therapeutics that improve cancer treatment options for patients.

Issuer Information

NAICS: Pharmaceutical P
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 0.06 52 Wk Low 0.03
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 158,716,893.00 EPS (TTM) -0.28 PE Ratio N/A Exchange OTCPK
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Gerardo Canet 1,000
Gregory T. Schiffman 1,000
John H. Johnson 1,000
Susan B. Bayh 1,000
Mark Frohlich 1,000
Last 10 Sell Shares
Mark Frohlich 1,000
Mark Frohlich 1,000
Mark Frohlich 1,000
David L. Urdal 1,000
Mark Frohlich 1,000
David L. Urdal 1,000
David L. Urdal 1,000
Mitchell H. Gold 1,000
Mitchell H. Gold 1,000
David L. Urdal 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 10/21/14 10/21/14 10/21/14 10/21/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3